HPLC Purity Standards for Research Peptides
What ≥98% by HPLC actually means, how the chromatogram is integrated, common impurity profiles, and why third-party verification matters.
HPLC purity is the single most-reported metric on a peptide COA. It is also one of the most misunderstood. This article explains what the headline percentage actually represents, how the underlying chromatogram is read, and why third-party verification is the only meaningful guarantee.
What HPLC measures
High-performance liquid chromatography separates the components of a mixture by their interaction with a stationary phase under high pressure. For peptides, the standard configuration is reversed-phase HPLC: a hydrophobic C18 stationary phase, with elution by a gradient of acetonitrile in water acidified with trifluoroacetic acid. UV detection at 220 nm captures the peptide bond absorbance.
Reading the chromatogram
The chromatogram is a plot of detector response (absorbance) against retention time. The peptide of interest appears as a peak. Smaller peaks before or after represent impurities — typically truncated sequences, deletion products, oxidation products, or residual reagents.
Purity is calculated as the area under the main peak divided by the total integrated area, expressed as a percentage. A clean main peak with a narrow base and a flat baseline is what a well-purified peptide looks like.
The 98% standard
The conventional threshold for research-grade peptides is ≥98% by HPLC. Below this, contaminants begin to interfere with downstream assays. Above approximately 99.5%, the cost of further purification rises sharply while incremental experimental benefit drops. The Pillar Research catalogue averages above 99%; individual batches are reported to 0.1% precision on the COA.
Common impurity profiles
- Deletion peptides — sequences missing one residue, typically eluting close to the main peak
- Truncation products — sequences missing several N-terminal or C-terminal residues, eluting earlier
- Oxidation products — methionine or tryptophan oxidation, +16 Da per oxygen, eluting earlier than the main peak
- Acetate / TFA salt counter-ions — these affect peptide content but not HPLC purity per se; they are reported separately
Third-party verification
A manufacturer-only COA is a self-report. Third-party verification — analysis by an independent laboratory with no commercial interest in the result — is the only credible guarantee. Pillar Research uses an independent Australian laboratory for every batch. We do not conduct in-house testing, and we will not release material on the basis of a manufacturer COA alone.
For a full walkthrough of what a complete COA contains and the red flags that mark sub-standard supply, see our COA reading guide.
This compound is supplied for in vitro laboratory and educational research only. It is not listed on the Australian Register of Therapeutic Goods (ARTG) and is not a therapeutic good under the Therapeutic Goods Act 1989 (Cth). Not for human or animal consumption, therapeutic use, or diagnostic procedures. By purchasing, you confirm you are a qualified researcher or acting on behalf of a licensed research facility, and you assume full responsibility for the safe handling, storage, and lawful use of this compound.